TOKYO -- U.S. proxy advisory firm Institutional Shareholder Services (ISS) is recommending shareholders vote against the reelection of Takeda Pharmaceuticals CEO Christophe Weber to the Japanese drugmaker's board, according to Takeda.
Pharmaceuticals
Takeda CEO Christophe Weber faces opposition to board reelection
Proxy adviser ISS also calls for voting down proposed bonuses for directors
Proxy adviser ISS is recommending that shareholders vote against the reelection of Takeda Pharmaceutical President and CEO Christophe Weber to the drugmaker's board. (Source photos by Nikkei)
Read Next
.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on Pharmaceuticals
